Global Biologics CDMO Services Supply, Demand and Key Producers, 2024-2030
The global Biologics CDMO Services market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global Biologics CDMO Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biologics CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biologics CDMO Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biologics CDMO Services total market, 2019-2030, (USD Million)
Global Biologics CDMO Services total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Biologics CDMO Services total market, key domestic companies and share, (USD Million)
Global Biologics CDMO Services revenue by player and market share 2019-2024, (USD Million)
Global Biologics CDMO Services total market by Type, CAGR, 2019-2030, (USD Million)
Global Biologics CDMO Services total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Biologics CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, WuXi AppTech, Recipharm, Thermo Fisher Scientific and AGC Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biologics CDMO Services market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Biologics CDMO Services Market, By Region:
1. How big is the global Biologics CDMO Services market?
2. What is the demand of the global Biologics CDMO Services market?
3. What is the year over year growth of the global Biologics CDMO Services market?
4. What is the total value of the global Biologics CDMO Services market?
5. Who are the major players in the global Biologics CDMO Services market?
This report studies the global Biologics CDMO Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biologics CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biologics CDMO Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biologics CDMO Services total market, 2019-2030, (USD Million)
Global Biologics CDMO Services total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Biologics CDMO Services total market, key domestic companies and share, (USD Million)
Global Biologics CDMO Services revenue by player and market share 2019-2024, (USD Million)
Global Biologics CDMO Services total market by Type, CAGR, 2019-2030, (USD Million)
Global Biologics CDMO Services total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Biologics CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, WuXi AppTech, Recipharm, Thermo Fisher Scientific and AGC Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biologics CDMO Services market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Biologics CDMO Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cell and Gene Therapies
- Antibodies
- Vaccines
- Other
- SMBs
- Large Companies
- Lonza
- Catalent
- Samsung Biologics
- FUJIFILM Diosynth Biotechnologies
- Boehringer Ingelheim
- WuXi AppTech
- Recipharm
- Thermo Fisher Scientific
- AGC Biologics
- Rentschler Biopharma
- KBI Biopharma
- Siegfried
- Aenova Group
- GenScript
- ProBioGen
- Northway Biotech
- 3P Biopharmaceuticals
1. How big is the global Biologics CDMO Services market?
2. What is the demand of the global Biologics CDMO Services market?
3. What is the year over year growth of the global Biologics CDMO Services market?
4. What is the total value of the global Biologics CDMO Services market?
5. Who are the major players in the global Biologics CDMO Services market?
1 SUPPLY SUMMARY
1.1 Biologics CDMO Services Introduction
1.2 World Biologics CDMO Services Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Biologics CDMO Services Total Market by Region (by Headquarter Location)
1.3.1 World Biologics CDMO Services Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Biologics CDMO Services Market Size (2019-2030)
1.3.3 China Biologics CDMO Services Market Size (2019-2030)
1.3.4 Europe Biologics CDMO Services Market Size (2019-2030)
1.3.5 Japan Biologics CDMO Services Market Size (2019-2030)
1.3.6 South Korea Biologics CDMO Services Market Size (2019-2030)
1.3.7 ASEAN Biologics CDMO Services Market Size (2019-2030)
1.3.8 India Biologics CDMO Services Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biologics CDMO Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biologics CDMO Services Major Market Trends
2 DEMAND SUMMARY
2.1 World Biologics CDMO Services Consumption Value (2019-2030)
2.2 World Biologics CDMO Services Consumption Value by Region
2.2.1 World Biologics CDMO Services Consumption Value by Region (2019-2024)
2.2.2 World Biologics CDMO Services Consumption Value Forecast by Region (2025-2030)
2.3 United States Biologics CDMO Services Consumption Value (2019-2030)
2.4 China Biologics CDMO Services Consumption Value (2019-2030)
2.5 Europe Biologics CDMO Services Consumption Value (2019-2030)
2.6 Japan Biologics CDMO Services Consumption Value (2019-2030)
2.7 South Korea Biologics CDMO Services Consumption Value (2019-2030)
2.8 ASEAN Biologics CDMO Services Consumption Value (2019-2030)
2.9 India Biologics CDMO Services Consumption Value (2019-2030)
3 WORLD BIOLOGICS CDMO SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Biologics CDMO Services Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biologics CDMO Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biologics CDMO Services in 2023
3.2.3 Global Concentration Ratios (CR8) for Biologics CDMO Services in 2023
3.3 Biologics CDMO Services Company Evaluation Quadrant
3.4 Biologics CDMO Services Market: Overall Company Footprint Analysis
3.4.1 Biologics CDMO Services Market: Region Footprint
3.4.2 Biologics CDMO Services Market: Company Product Type Footprint
3.4.3 Biologics CDMO Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biologics CDMO Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biologics CDMO Services Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Biologics CDMO Services Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Biologics CDMO Services Consumption Value Comparison
4.2.1 United States VS China: Biologics CDMO Services Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Biologics CDMO Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Biologics CDMO Services Companies and Market Share, 2019-2024
4.3.1 United States Based Biologics CDMO Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biologics CDMO Services Revenue, (2019-2024)
4.4 China Based Companies Biologics CDMO Services Revenue and Market Share, 2019-2024
4.4.1 China Based Biologics CDMO Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biologics CDMO Services Revenue, (2019-2024)
4.5 Rest of World Based Biologics CDMO Services Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Biologics CDMO Services Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biologics CDMO Services Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Biologics CDMO Services Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Cell and Gene Therapies
5.2.2 Antibodies
5.2.3 Vaccines
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Biologics CDMO Services Market Size by Type (2019-2024)
5.3.2 World Biologics CDMO Services Market Size by Type (2025-2030)
5.3.3 World Biologics CDMO Services Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biologics CDMO Services Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 SMBs
6.2.2 Large Companies
6.3 Market Segment by Application
6.3.1 World Biologics CDMO Services Market Size by Application (2019-2024)
6.3.2 World Biologics CDMO Services Market Size by Application (2025-2030)
6.3.3 World Biologics CDMO Services Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Biologics CDMO Services Product and Services
7.1.4 Lonza Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Catalent
7.2.1 Catalent Details
7.2.2 Catalent Major Business
7.2.3 Catalent Biologics CDMO Services Product and Services
7.2.4 Catalent Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Catalent Recent Developments/Updates
7.2.6 Catalent Competitive Strengths & Weaknesses
7.3 Samsung Biologics
7.3.1 Samsung Biologics Details
7.3.2 Samsung Biologics Major Business
7.3.3 Samsung Biologics Biologics CDMO Services Product and Services
7.3.4 Samsung Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Samsung Biologics Recent Developments/Updates
7.3.6 Samsung Biologics Competitive Strengths & Weaknesses
7.4 FUJIFILM Diosynth Biotechnologies
7.4.1 FUJIFILM Diosynth Biotechnologies Details
7.4.2 FUJIFILM Diosynth Biotechnologies Major Business
7.4.3 FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Product and Services
7.4.4 FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.4.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Details
7.5.2 Boehringer Ingelheim Major Business
7.5.3 Boehringer Ingelheim Biologics CDMO Services Product and Services
7.5.4 Boehringer Ingelheim Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Boehringer Ingelheim Recent Developments/Updates
7.5.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.6 WuXi AppTech
7.6.1 WuXi AppTech Details
7.6.2 WuXi AppTech Major Business
7.6.3 WuXi AppTech Biologics CDMO Services Product and Services
7.6.4 WuXi AppTech Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 WuXi AppTech Recent Developments/Updates
7.6.6 WuXi AppTech Competitive Strengths & Weaknesses
7.7 Recipharm
7.7.1 Recipharm Details
7.7.2 Recipharm Major Business
7.7.3 Recipharm Biologics CDMO Services Product and Services
7.7.4 Recipharm Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Recipharm Recent Developments/Updates
7.7.6 Recipharm Competitive Strengths & Weaknesses
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Details
7.8.2 Thermo Fisher Scientific Major Business
7.8.3 Thermo Fisher Scientific Biologics CDMO Services Product and Services
7.8.4 Thermo Fisher Scientific Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Thermo Fisher Scientific Recent Developments/Updates
7.8.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.9 AGC Biologics
7.9.1 AGC Biologics Details
7.9.2 AGC Biologics Major Business
7.9.3 AGC Biologics Biologics CDMO Services Product and Services
7.9.4 AGC Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 AGC Biologics Recent Developments/Updates
7.9.6 AGC Biologics Competitive Strengths & Weaknesses
7.10 Rentschler Biopharma
7.10.1 Rentschler Biopharma Details
7.10.2 Rentschler Biopharma Major Business
7.10.3 Rentschler Biopharma Biologics CDMO Services Product and Services
7.10.4 Rentschler Biopharma Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Rentschler Biopharma Recent Developments/Updates
7.10.6 Rentschler Biopharma Competitive Strengths & Weaknesses
7.11 KBI Biopharma
7.11.1 KBI Biopharma Details
7.11.2 KBI Biopharma Major Business
7.11.3 KBI Biopharma Biologics CDMO Services Product and Services
7.11.4 KBI Biopharma Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 KBI Biopharma Recent Developments/Updates
7.11.6 KBI Biopharma Competitive Strengths & Weaknesses
7.12 Siegfried
7.12.1 Siegfried Details
7.12.2 Siegfried Major Business
7.12.3 Siegfried Biologics CDMO Services Product and Services
7.12.4 Siegfried Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Siegfried Recent Developments/Updates
7.12.6 Siegfried Competitive Strengths & Weaknesses
7.13 Aenova Group
7.13.1 Aenova Group Details
7.13.2 Aenova Group Major Business
7.13.3 Aenova Group Biologics CDMO Services Product and Services
7.13.4 Aenova Group Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Aenova Group Recent Developments/Updates
7.13.6 Aenova Group Competitive Strengths & Weaknesses
7.14 GenScript
7.14.1 GenScript Details
7.14.2 GenScript Major Business
7.14.3 GenScript Biologics CDMO Services Product and Services
7.14.4 GenScript Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 GenScript Recent Developments/Updates
7.14.6 GenScript Competitive Strengths & Weaknesses
7.15 ProBioGen
7.15.1 ProBioGen Details
7.15.2 ProBioGen Major Business
7.15.3 ProBioGen Biologics CDMO Services Product and Services
7.15.4 ProBioGen Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 ProBioGen Recent Developments/Updates
7.15.6 ProBioGen Competitive Strengths & Weaknesses
7.16 Northway Biotech
7.16.1 Northway Biotech Details
7.16.2 Northway Biotech Major Business
7.16.3 Northway Biotech Biologics CDMO Services Product and Services
7.16.4 Northway Biotech Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Northway Biotech Recent Developments/Updates
7.16.6 Northway Biotech Competitive Strengths & Weaknesses
7.17 3P Biopharmaceuticals
7.17.1 3P Biopharmaceuticals Details
7.17.2 3P Biopharmaceuticals Major Business
7.17.3 3P Biopharmaceuticals Biologics CDMO Services Product and Services
7.17.4 3P Biopharmaceuticals Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 3P Biopharmaceuticals Recent Developments/Updates
7.17.6 3P Biopharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biologics CDMO Services Industry Chain
8.2 Biologics CDMO Services Upstream Analysis
8.3 Biologics CDMO Services Midstream Analysis
8.4 Biologics CDMO Services Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Biologics CDMO Services Introduction
1.2 World Biologics CDMO Services Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Biologics CDMO Services Total Market by Region (by Headquarter Location)
1.3.1 World Biologics CDMO Services Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Biologics CDMO Services Market Size (2019-2030)
1.3.3 China Biologics CDMO Services Market Size (2019-2030)
1.3.4 Europe Biologics CDMO Services Market Size (2019-2030)
1.3.5 Japan Biologics CDMO Services Market Size (2019-2030)
1.3.6 South Korea Biologics CDMO Services Market Size (2019-2030)
1.3.7 ASEAN Biologics CDMO Services Market Size (2019-2030)
1.3.8 India Biologics CDMO Services Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biologics CDMO Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biologics CDMO Services Major Market Trends
2 DEMAND SUMMARY
2.1 World Biologics CDMO Services Consumption Value (2019-2030)
2.2 World Biologics CDMO Services Consumption Value by Region
2.2.1 World Biologics CDMO Services Consumption Value by Region (2019-2024)
2.2.2 World Biologics CDMO Services Consumption Value Forecast by Region (2025-2030)
2.3 United States Biologics CDMO Services Consumption Value (2019-2030)
2.4 China Biologics CDMO Services Consumption Value (2019-2030)
2.5 Europe Biologics CDMO Services Consumption Value (2019-2030)
2.6 Japan Biologics CDMO Services Consumption Value (2019-2030)
2.7 South Korea Biologics CDMO Services Consumption Value (2019-2030)
2.8 ASEAN Biologics CDMO Services Consumption Value (2019-2030)
2.9 India Biologics CDMO Services Consumption Value (2019-2030)
3 WORLD BIOLOGICS CDMO SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Biologics CDMO Services Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biologics CDMO Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biologics CDMO Services in 2023
3.2.3 Global Concentration Ratios (CR8) for Biologics CDMO Services in 2023
3.3 Biologics CDMO Services Company Evaluation Quadrant
3.4 Biologics CDMO Services Market: Overall Company Footprint Analysis
3.4.1 Biologics CDMO Services Market: Region Footprint
3.4.2 Biologics CDMO Services Market: Company Product Type Footprint
3.4.3 Biologics CDMO Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biologics CDMO Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biologics CDMO Services Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Biologics CDMO Services Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Biologics CDMO Services Consumption Value Comparison
4.2.1 United States VS China: Biologics CDMO Services Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Biologics CDMO Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Biologics CDMO Services Companies and Market Share, 2019-2024
4.3.1 United States Based Biologics CDMO Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biologics CDMO Services Revenue, (2019-2024)
4.4 China Based Companies Biologics CDMO Services Revenue and Market Share, 2019-2024
4.4.1 China Based Biologics CDMO Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biologics CDMO Services Revenue, (2019-2024)
4.5 Rest of World Based Biologics CDMO Services Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Biologics CDMO Services Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biologics CDMO Services Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Biologics CDMO Services Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Cell and Gene Therapies
5.2.2 Antibodies
5.2.3 Vaccines
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Biologics CDMO Services Market Size by Type (2019-2024)
5.3.2 World Biologics CDMO Services Market Size by Type (2025-2030)
5.3.3 World Biologics CDMO Services Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biologics CDMO Services Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 SMBs
6.2.2 Large Companies
6.3 Market Segment by Application
6.3.1 World Biologics CDMO Services Market Size by Application (2019-2024)
6.3.2 World Biologics CDMO Services Market Size by Application (2025-2030)
6.3.3 World Biologics CDMO Services Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Biologics CDMO Services Product and Services
7.1.4 Lonza Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Catalent
7.2.1 Catalent Details
7.2.2 Catalent Major Business
7.2.3 Catalent Biologics CDMO Services Product and Services
7.2.4 Catalent Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Catalent Recent Developments/Updates
7.2.6 Catalent Competitive Strengths & Weaknesses
7.3 Samsung Biologics
7.3.1 Samsung Biologics Details
7.3.2 Samsung Biologics Major Business
7.3.3 Samsung Biologics Biologics CDMO Services Product and Services
7.3.4 Samsung Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Samsung Biologics Recent Developments/Updates
7.3.6 Samsung Biologics Competitive Strengths & Weaknesses
7.4 FUJIFILM Diosynth Biotechnologies
7.4.1 FUJIFILM Diosynth Biotechnologies Details
7.4.2 FUJIFILM Diosynth Biotechnologies Major Business
7.4.3 FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Product and Services
7.4.4 FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.4.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Details
7.5.2 Boehringer Ingelheim Major Business
7.5.3 Boehringer Ingelheim Biologics CDMO Services Product and Services
7.5.4 Boehringer Ingelheim Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Boehringer Ingelheim Recent Developments/Updates
7.5.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.6 WuXi AppTech
7.6.1 WuXi AppTech Details
7.6.2 WuXi AppTech Major Business
7.6.3 WuXi AppTech Biologics CDMO Services Product and Services
7.6.4 WuXi AppTech Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 WuXi AppTech Recent Developments/Updates
7.6.6 WuXi AppTech Competitive Strengths & Weaknesses
7.7 Recipharm
7.7.1 Recipharm Details
7.7.2 Recipharm Major Business
7.7.3 Recipharm Biologics CDMO Services Product and Services
7.7.4 Recipharm Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Recipharm Recent Developments/Updates
7.7.6 Recipharm Competitive Strengths & Weaknesses
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Details
7.8.2 Thermo Fisher Scientific Major Business
7.8.3 Thermo Fisher Scientific Biologics CDMO Services Product and Services
7.8.4 Thermo Fisher Scientific Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Thermo Fisher Scientific Recent Developments/Updates
7.8.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.9 AGC Biologics
7.9.1 AGC Biologics Details
7.9.2 AGC Biologics Major Business
7.9.3 AGC Biologics Biologics CDMO Services Product and Services
7.9.4 AGC Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 AGC Biologics Recent Developments/Updates
7.9.6 AGC Biologics Competitive Strengths & Weaknesses
7.10 Rentschler Biopharma
7.10.1 Rentschler Biopharma Details
7.10.2 Rentschler Biopharma Major Business
7.10.3 Rentschler Biopharma Biologics CDMO Services Product and Services
7.10.4 Rentschler Biopharma Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Rentschler Biopharma Recent Developments/Updates
7.10.6 Rentschler Biopharma Competitive Strengths & Weaknesses
7.11 KBI Biopharma
7.11.1 KBI Biopharma Details
7.11.2 KBI Biopharma Major Business
7.11.3 KBI Biopharma Biologics CDMO Services Product and Services
7.11.4 KBI Biopharma Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 KBI Biopharma Recent Developments/Updates
7.11.6 KBI Biopharma Competitive Strengths & Weaknesses
7.12 Siegfried
7.12.1 Siegfried Details
7.12.2 Siegfried Major Business
7.12.3 Siegfried Biologics CDMO Services Product and Services
7.12.4 Siegfried Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Siegfried Recent Developments/Updates
7.12.6 Siegfried Competitive Strengths & Weaknesses
7.13 Aenova Group
7.13.1 Aenova Group Details
7.13.2 Aenova Group Major Business
7.13.3 Aenova Group Biologics CDMO Services Product and Services
7.13.4 Aenova Group Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Aenova Group Recent Developments/Updates
7.13.6 Aenova Group Competitive Strengths & Weaknesses
7.14 GenScript
7.14.1 GenScript Details
7.14.2 GenScript Major Business
7.14.3 GenScript Biologics CDMO Services Product and Services
7.14.4 GenScript Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 GenScript Recent Developments/Updates
7.14.6 GenScript Competitive Strengths & Weaknesses
7.15 ProBioGen
7.15.1 ProBioGen Details
7.15.2 ProBioGen Major Business
7.15.3 ProBioGen Biologics CDMO Services Product and Services
7.15.4 ProBioGen Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 ProBioGen Recent Developments/Updates
7.15.6 ProBioGen Competitive Strengths & Weaknesses
7.16 Northway Biotech
7.16.1 Northway Biotech Details
7.16.2 Northway Biotech Major Business
7.16.3 Northway Biotech Biologics CDMO Services Product and Services
7.16.4 Northway Biotech Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Northway Biotech Recent Developments/Updates
7.16.6 Northway Biotech Competitive Strengths & Weaknesses
7.17 3P Biopharmaceuticals
7.17.1 3P Biopharmaceuticals Details
7.17.2 3P Biopharmaceuticals Major Business
7.17.3 3P Biopharmaceuticals Biologics CDMO Services Product and Services
7.17.4 3P Biopharmaceuticals Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 3P Biopharmaceuticals Recent Developments/Updates
7.17.6 3P Biopharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biologics CDMO Services Industry Chain
8.2 Biologics CDMO Services Upstream Analysis
8.3 Biologics CDMO Services Midstream Analysis
8.4 Biologics CDMO Services Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Biologics CDMO Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Biologics CDMO Services Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Biologics CDMO Services Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Biologics CDMO Services Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Biologics CDMO Services Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biologics CDMO Services Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Biologics CDMO Services Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Biologics CDMO Services Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Biologics CDMO Services Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Biologics CDMO Services Players in 2023
Table 12. World Biologics CDMO Services Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Biologics CDMO Services Company Evaluation Quadrant
Table 14. Head Office of Key Biologics CDMO Services Player
Table 15. Biologics CDMO Services Market: Company Product Type Footprint
Table 16. Biologics CDMO Services Market: Company Product Application Footprint
Table 17. Biologics CDMO Services Mergers & Acquisitions Activity
Table 18. United States VS China Biologics CDMO Services Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Biologics CDMO Services Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Biologics CDMO Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biologics CDMO Services Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Biologics CDMO Services Revenue Market Share (2019-2024)
Table 23. China Based Biologics CDMO Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biologics CDMO Services Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Biologics CDMO Services Revenue Market Share (2019-2024)
Table 26. Rest of World Based Biologics CDMO Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biologics CDMO Services Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Biologics CDMO Services Revenue Market Share (2019-2024)
Table 29. World Biologics CDMO Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Biologics CDMO Services Market Size by Type (2019-2024) & (USD Million)
Table 31. World Biologics CDMO Services Market Size by Type (2025-2030) & (USD Million)
Table 32. World Biologics CDMO Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Biologics CDMO Services Market Size by Application (2019-2024) & (USD Million)
Table 34. World Biologics CDMO Services Market Size by Application (2025-2030) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Biologics CDMO Services Product and Services
Table 38. Lonza Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Catalent Basic Information, Area Served and Competitors
Table 42. Catalent Major Business
Table 43. Catalent Biologics CDMO Services Product and Services
Table 44. Catalent Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Catalent Recent Developments/Updates
Table 46. Catalent Competitive Strengths & Weaknesses
Table 47. Samsung Biologics Basic Information, Area Served and Competitors
Table 48. Samsung Biologics Major Business
Table 49. Samsung Biologics Biologics CDMO Services Product and Services
Table 50. Samsung Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Samsung Biologics Recent Developments/Updates
Table 52. Samsung Biologics Competitive Strengths & Weaknesses
Table 53. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 54. FUJIFILM Diosynth Biotechnologies Major Business
Table 55. FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Product and Services
Table 56. FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 58. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 59. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 60. Boehringer Ingelheim Major Business
Table 61. Boehringer Ingelheim Biologics CDMO Services Product and Services
Table 62. Boehringer Ingelheim Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Boehringer Ingelheim Recent Developments/Updates
Table 64. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 65. WuXi AppTech Basic Information, Area Served and Competitors
Table 66. WuXi AppTech Major Business
Table 67. WuXi AppTech Biologics CDMO Services Product and Services
Table 68. WuXi AppTech Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. WuXi AppTech Recent Developments/Updates
Table 70. WuXi AppTech Competitive Strengths & Weaknesses
Table 71. Recipharm Basic Information, Area Served and Competitors
Table 72. Recipharm Major Business
Table 73. Recipharm Biologics CDMO Services Product and Services
Table 74. Recipharm Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Recipharm Recent Developments/Updates
Table 76. Recipharm Competitive Strengths & Weaknesses
Table 77. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 78. Thermo Fisher Scientific Major Business
Table 79. Thermo Fisher Scientific Biologics CDMO Services Product and Services
Table 80. Thermo Fisher Scientific Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Thermo Fisher Scientific Recent Developments/Updates
Table 82. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 83. AGC Biologics Basic Information, Area Served and Competitors
Table 84. AGC Biologics Major Business
Table 85. AGC Biologics Biologics CDMO Services Product and Services
Table 86. AGC Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. AGC Biologics Recent Developments/Updates
Table 88. AGC Biologics Competitive Strengths & Weaknesses
Table 89. Rentschler Biopharma Basic Information, Area Served and Competitors
Table 90. Rentschler Biopharma Major Business
Table 91. Rentschler Biopharma Biologics CDMO Services Product and Services
Table 92. Rentschler Biopharma Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Rentschler Biopharma Recent Developments/Updates
Table 94. Rentschler Biopharma Competitive Strengths & Weaknesses
Table 95. KBI Biopharma Basic Information, Area Served and Competitors
Table 96. KBI Biopharma Major Business
Table 97. KBI Biopharma Biologics CDMO Services Product and Services
Table 98. KBI Biopharma Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. KBI Biopharma Recent Developments/Updates
Table 100. KBI Biopharma Competitive Strengths & Weaknesses
Table 101. Siegfried Basic Information, Area Served and Competitors
Table 102. Siegfried Major Business
Table 103. Siegfried Biologics CDMO Services Product and Services
Table 104. Siegfried Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Siegfried Recent Developments/Updates
Table 106. Siegfried Competitive Strengths & Weaknesses
Table 107. Aenova Group Basic Information, Area Served and Competitors
Table 108. Aenova Group Major Business
Table 109. Aenova Group Biologics CDMO Services Product and Services
Table 110. Aenova Group Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Aenova Group Recent Developments/Updates
Table 112. Aenova Group Competitive Strengths & Weaknesses
Table 113. GenScript Basic Information, Area Served and Competitors
Table 114. GenScript Major Business
Table 115. GenScript Biologics CDMO Services Product and Services
Table 116. GenScript Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. GenScript Recent Developments/Updates
Table 118. GenScript Competitive Strengths & Weaknesses
Table 119. ProBioGen Basic Information, Area Served and Competitors
Table 120. ProBioGen Major Business
Table 121. ProBioGen Biologics CDMO Services Product and Services
Table 122. ProBioGen Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. ProBioGen Recent Developments/Updates
Table 124. ProBioGen Competitive Strengths & Weaknesses
Table 125. Northway Biotech Basic Information, Area Served and Competitors
Table 126. Northway Biotech Major Business
Table 127. Northway Biotech Biologics CDMO Services Product and Services
Table 128. Northway Biotech Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. Northway Biotech Recent Developments/Updates
Table 130. 3P Biopharmaceuticals Basic Information, Area Served and Competitors
Table 131. 3P Biopharmaceuticals Major Business
Table 132. 3P Biopharmaceuticals Biologics CDMO Services Product and Services
Table 133. 3P Biopharmaceuticals Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 134. Global Key Players of Biologics CDMO Services Upstream (Raw Materials)
Table 135. Biologics CDMO Services Typical Customers
LIST OF FIGURE
Figure 1. Biologics CDMO Services Picture
Figure 2. World Biologics CDMO Services Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Biologics CDMO Services Total Market Size (2019-2030) & (USD Million)
Figure 4. World Biologics CDMO Services Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Biologics CDMO Services Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 13. Biologics CDMO Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 16. World Biologics CDMO Services Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 18. China Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 23. India Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Biologics CDMO Services by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biologics CDMO Services Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biologics CDMO Services Markets in 2023
Figure 27. United States VS China: Biologics CDMO Services Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Biologics CDMO Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Biologics CDMO Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Biologics CDMO Services Market Size Market Share by Type in 2023
Figure 31. Cell and Gene Therapies
Figure 32. Antibodies
Figure 33. Vaccines
Figure 34. Other
Figure 35. World Biologics CDMO Services Market Size Market Share by Type (2019-2030)
Figure 36. World Biologics CDMO Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 37. World Biologics CDMO Services Market Size Market Share by Application in 2023
Figure 38. SMBs
Figure 39. Large Companies
Figure 40. Biologics CDMO Services Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Table 1. World Biologics CDMO Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Biologics CDMO Services Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Biologics CDMO Services Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Biologics CDMO Services Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Biologics CDMO Services Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biologics CDMO Services Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Biologics CDMO Services Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Biologics CDMO Services Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Biologics CDMO Services Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Biologics CDMO Services Players in 2023
Table 12. World Biologics CDMO Services Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Biologics CDMO Services Company Evaluation Quadrant
Table 14. Head Office of Key Biologics CDMO Services Player
Table 15. Biologics CDMO Services Market: Company Product Type Footprint
Table 16. Biologics CDMO Services Market: Company Product Application Footprint
Table 17. Biologics CDMO Services Mergers & Acquisitions Activity
Table 18. United States VS China Biologics CDMO Services Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Biologics CDMO Services Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Biologics CDMO Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biologics CDMO Services Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Biologics CDMO Services Revenue Market Share (2019-2024)
Table 23. China Based Biologics CDMO Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biologics CDMO Services Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Biologics CDMO Services Revenue Market Share (2019-2024)
Table 26. Rest of World Based Biologics CDMO Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biologics CDMO Services Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Biologics CDMO Services Revenue Market Share (2019-2024)
Table 29. World Biologics CDMO Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Biologics CDMO Services Market Size by Type (2019-2024) & (USD Million)
Table 31. World Biologics CDMO Services Market Size by Type (2025-2030) & (USD Million)
Table 32. World Biologics CDMO Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Biologics CDMO Services Market Size by Application (2019-2024) & (USD Million)
Table 34. World Biologics CDMO Services Market Size by Application (2025-2030) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Biologics CDMO Services Product and Services
Table 38. Lonza Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Catalent Basic Information, Area Served and Competitors
Table 42. Catalent Major Business
Table 43. Catalent Biologics CDMO Services Product and Services
Table 44. Catalent Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Catalent Recent Developments/Updates
Table 46. Catalent Competitive Strengths & Weaknesses
Table 47. Samsung Biologics Basic Information, Area Served and Competitors
Table 48. Samsung Biologics Major Business
Table 49. Samsung Biologics Biologics CDMO Services Product and Services
Table 50. Samsung Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Samsung Biologics Recent Developments/Updates
Table 52. Samsung Biologics Competitive Strengths & Weaknesses
Table 53. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 54. FUJIFILM Diosynth Biotechnologies Major Business
Table 55. FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Product and Services
Table 56. FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 58. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 59. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 60. Boehringer Ingelheim Major Business
Table 61. Boehringer Ingelheim Biologics CDMO Services Product and Services
Table 62. Boehringer Ingelheim Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Boehringer Ingelheim Recent Developments/Updates
Table 64. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 65. WuXi AppTech Basic Information, Area Served and Competitors
Table 66. WuXi AppTech Major Business
Table 67. WuXi AppTech Biologics CDMO Services Product and Services
Table 68. WuXi AppTech Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. WuXi AppTech Recent Developments/Updates
Table 70. WuXi AppTech Competitive Strengths & Weaknesses
Table 71. Recipharm Basic Information, Area Served and Competitors
Table 72. Recipharm Major Business
Table 73. Recipharm Biologics CDMO Services Product and Services
Table 74. Recipharm Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Recipharm Recent Developments/Updates
Table 76. Recipharm Competitive Strengths & Weaknesses
Table 77. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 78. Thermo Fisher Scientific Major Business
Table 79. Thermo Fisher Scientific Biologics CDMO Services Product and Services
Table 80. Thermo Fisher Scientific Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Thermo Fisher Scientific Recent Developments/Updates
Table 82. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 83. AGC Biologics Basic Information, Area Served and Competitors
Table 84. AGC Biologics Major Business
Table 85. AGC Biologics Biologics CDMO Services Product and Services
Table 86. AGC Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. AGC Biologics Recent Developments/Updates
Table 88. AGC Biologics Competitive Strengths & Weaknesses
Table 89. Rentschler Biopharma Basic Information, Area Served and Competitors
Table 90. Rentschler Biopharma Major Business
Table 91. Rentschler Biopharma Biologics CDMO Services Product and Services
Table 92. Rentschler Biopharma Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Rentschler Biopharma Recent Developments/Updates
Table 94. Rentschler Biopharma Competitive Strengths & Weaknesses
Table 95. KBI Biopharma Basic Information, Area Served and Competitors
Table 96. KBI Biopharma Major Business
Table 97. KBI Biopharma Biologics CDMO Services Product and Services
Table 98. KBI Biopharma Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. KBI Biopharma Recent Developments/Updates
Table 100. KBI Biopharma Competitive Strengths & Weaknesses
Table 101. Siegfried Basic Information, Area Served and Competitors
Table 102. Siegfried Major Business
Table 103. Siegfried Biologics CDMO Services Product and Services
Table 104. Siegfried Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Siegfried Recent Developments/Updates
Table 106. Siegfried Competitive Strengths & Weaknesses
Table 107. Aenova Group Basic Information, Area Served and Competitors
Table 108. Aenova Group Major Business
Table 109. Aenova Group Biologics CDMO Services Product and Services
Table 110. Aenova Group Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Aenova Group Recent Developments/Updates
Table 112. Aenova Group Competitive Strengths & Weaknesses
Table 113. GenScript Basic Information, Area Served and Competitors
Table 114. GenScript Major Business
Table 115. GenScript Biologics CDMO Services Product and Services
Table 116. GenScript Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. GenScript Recent Developments/Updates
Table 118. GenScript Competitive Strengths & Weaknesses
Table 119. ProBioGen Basic Information, Area Served and Competitors
Table 120. ProBioGen Major Business
Table 121. ProBioGen Biologics CDMO Services Product and Services
Table 122. ProBioGen Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. ProBioGen Recent Developments/Updates
Table 124. ProBioGen Competitive Strengths & Weaknesses
Table 125. Northway Biotech Basic Information, Area Served and Competitors
Table 126. Northway Biotech Major Business
Table 127. Northway Biotech Biologics CDMO Services Product and Services
Table 128. Northway Biotech Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. Northway Biotech Recent Developments/Updates
Table 130. 3P Biopharmaceuticals Basic Information, Area Served and Competitors
Table 131. 3P Biopharmaceuticals Major Business
Table 132. 3P Biopharmaceuticals Biologics CDMO Services Product and Services
Table 133. 3P Biopharmaceuticals Biologics CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 134. Global Key Players of Biologics CDMO Services Upstream (Raw Materials)
Table 135. Biologics CDMO Services Typical Customers
LIST OF FIGURE
Figure 1. Biologics CDMO Services Picture
Figure 2. World Biologics CDMO Services Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Biologics CDMO Services Total Market Size (2019-2030) & (USD Million)
Figure 4. World Biologics CDMO Services Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Biologics CDMO Services Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Biologics CDMO Services Revenue (2019-2030) & (USD Million)
Figure 13. Biologics CDMO Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 16. World Biologics CDMO Services Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 18. China Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 23. India Biologics CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Biologics CDMO Services by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biologics CDMO Services Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biologics CDMO Services Markets in 2023
Figure 27. United States VS China: Biologics CDMO Services Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Biologics CDMO Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Biologics CDMO Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Biologics CDMO Services Market Size Market Share by Type in 2023
Figure 31. Cell and Gene Therapies
Figure 32. Antibodies
Figure 33. Vaccines
Figure 34. Other
Figure 35. World Biologics CDMO Services Market Size Market Share by Type (2019-2030)
Figure 36. World Biologics CDMO Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 37. World Biologics CDMO Services Market Size Market Share by Application in 2023
Figure 38. SMBs
Figure 39. Large Companies
Figure 40. Biologics CDMO Services Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
